Health

Most pharma companies want to ensure their drugs are effective for the greatest portion of the patient populations they are designed to treat. An important part of designing effective clinical …

Fawad Butt doesn’t mince words when talking about the healthcare AI boom. As CEO of Penguin Ai, he has watched the market become flooded with startups promising transformative technology — …

Hunter syndrome patients can manage the disorder with a drug that addresses disease symptoms throughout the body except the brain — a key limitation for treating this rare neurological disorder. …

As a member of the Coalition Against Surprise Medical Billing, Katy Spangler helped push for the No Surprises Act in 2020. However, on Wednesday, she took the stage at the …

Cell and gene therapies (CGTs) are built on living systems. From early research through commercial distribution, the integrity of those systems depends on the ability to preserve cells without compromising …

In the past few years, payers and providers have been engaged in an arms race when it comes to deploying AI, with insurers using the technology to deny claims faster …

H.R. 1, referred to as the One Massive Lovely Invoice Act, will enact vital modifications to Medicaid in January 2027, together with work necessities for sure enrollees to keep up …

Merck is choosing up a giant new piece for its most cancers drug pipeline with a $6.7 billion deal to purchase Terns Prescribed drugs, an organization whose lead program may …

A crucial second is unfolding in medication, pushed by two stark generational divides: residents and fellows report burnout at greater charges and at earlier levels of their careers than their …

Affordability is prime of thoughts for executives at AHIP as People battle skyrocketing healthcare prices. “We’re laser-focused on affordability at AHIP,” stated Mike Tuffin, president and CEO of AHIP. “That’s, …